A randomized, placebo-controlled trial of quetiapine (Seroquel) monotherapy in the treatment of PTSD [Post-Traumatic Stress Disorder]
Phase of Trial: Phase IV
Latest Information Update: 15 Jul 2016
At a glance
- Drugs Quetiapine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 15 Jul 2016 Results published in the American Journal of Psychiatry (2016).
- 15 Sep 2009 Results presented at the 22nd Annual Congress of the European College of Neuropsychopharmacology.
- 26 Feb 2008 The expected completion date for this trial is now 1 Dec 2007.